CENPVL1: Potential Drug Targets for Brain and Blood-Brain Barrier Diseases

Target Name: CENPVL1

NCBI ID: G389857

CENPVL1

CENPVL1: Potential Drug Targets for Brain and Blood-Brain Barrier Diseases

CENPVL1 (CENPVL2) is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and muscle. It is a member of the Calbindin family of proteins, which are known for their ability to bind to and enhance the fluorescence of certain dyes, such as calorie brightening nitrooles.

One of the unique features of CENPVL1 is its ability to interact with the protein known as p21, which is a negative regulator of the T-cell receptor. This interaction between CENPVL1 and p21 has been shown to play a role in the regulation of immune responses and the development of certain diseases.

In addition to its role in immune regulation, CENPVL1 has also been shown to be involved in the regulation of cell survival and the development of cancer. For example, studies have shown that CENPVL1 can interact with the protein known as p53, which is a tumor suppressor protein that is often mutated in cancer cells. This interaction between CENPVL1 and p53 has led to the hypothesis that CENPVL1 may be a drug target (or biomarker) for certain types of cancer.

Another potential mechanism by which CENPVL1 may be involved in the development of certain diseases is its role in the regulation of the blood-brain barrier. The blood-brain barrier is a specialized barrier that separates the brain from the blood and helps to protect it from harmful substances. However, some diseases, such as Alzheimer's disease, are thought to involve the breakdown of the blood-brain barrier and the entry of toxic substances into the brain.

CENPVL1 has been shown to be involved in the regulation of the blood-brain barrier in several ways. For example, studies have shown that CENPVL1 can interact with the protein known as brain-derived neurotrophic factor (BDNF), which is a protein that is involved in the maintenance of the blood-brain barrier. This interaction between CENPVL1 and BDNF has led to the hypothesis that CENPVL1 may be a drug target (or biomarker) for certain types of neurodegenerative diseases.

In conclusion, CENPVL1 is a protein that is expressed in various tissues of the body and is involved in a number of important biological processes. Its ability to interact with the protein known as p21 and p53, as well as its role in the regulation of the blood-brain barrier, makes it a potential drug target (or biomarker) for a number of diseases. Further research is needed to fully understand the role of CENPVL1 in these processes and to develop effective treatments.

Protein Name: Centromere Protein V Like 1

The "CENPVL1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CENPVL1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets